News
Global Vaccine Production Drives Pharmaceutical CDMO Market
According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth could be attributed to the expanding pharmaceutical sector, driven by the increasing usage of analytics...
Clinical Trials
FDA Updates Recommendations To Modernize Clinical Trials
The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of clinical trials. The goal is to make trials more flexible while maintaining data accuracy and participant...
Drug Research
Innovative Partnership For RNA Medicine Delivery Solutions
The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP) formulations for delivering RNA-based medicines. This partnership, funded by a £10 million grant from Innovate...
Drug Research
Updated Vaccine Composition Strategy To Tackle New Strains
A report has been published by international regulators that highlights the outcomes of the discussion they had pertaining to COVID-19 vaccines, as well as the need for and the strategy so as to update the composition based on evidence...
News
Faster Access Via Recognition Routes – Initiative By MHRA
The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established by making use of approvals from Singapore, Canada, Japan, the US, Australia, Switzerland, and, of...
IT & Data Management
Mixed Reactions From Scientists As AI Emerges Pharma Sector
Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there happens to be a bifurcation of attitudes, with some researchers pretty much excited when it...
IT & Data Management
Blockchain Technology And Quality Control In Pharma Industry
In late 2020, Pfizer, a drug manufacturer, faced challenges in meeting its Covid-19 vaccine production targets due to quality issues with raw materials, causing disruptions in the global supply chain. The situation worsened in March 2021 when contamination issues...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.